| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Tuesday’s Close |
|---|---|---|---|---|---|
| ISRG | Intuitive Surgical, Inc. | $558.79 | $63.56B | Uptrend |
Here's Why You Should Buy Intuitive Surgical (ISRG) Now
http://www.zacks.com/stock/news/324336/heres-why-you-should-buy-intuitive-surgical-isrg-now?cid=CS-ZC-FT-324336
Sep 21, 2018 - Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.
0
Medtronic to Buy Mazor Robotics for Robotic Spine Surgery
http://www.zacks.com/stock/news/324334/medtronic-to-buy-mazor-robotics-for-robotic-spine-surgery?cid=CS-ZC-FT-324334
Sep 21, 2018 - The consolidation will combine Medtronic's (MDT) spine implants, navigation and intra-operative imaging technology with Mazor Robotics' robotic-assisted surgery (RAS) systems.
0
3 MedTech Stocks for Safe Returns as Hurricane Fears Peak
http://www.zacks.com/stock/news/324301/3-medtech-stocks-for-safe-returns-as-hurricane-fears-peak?cid=CS-ZC-FT-324301
Sep 21, 2018 - With the hurricane season at the peak, we bring three safe picks for investors.
0
Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now
http://www.zacks.com/stock/news/324260/heres-why-you-should-hold-becton-dickinson-bdx-stock-now?cid=CS-ZC-FT-324260
Sep 21, 2018 - Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.
0
Abbott Banks on New Approvals and Buyouts, Competition Rife
http://www.zacks.com/stock/news/324153/abbott-banks-on-new-approvals-and-buyouts-competition-rife?cid=CS-ZC-FT-324153
Sep 20, 2018 - Abbott's (ABT) receipt of FDA approval for XIENCE Sierra coronary stent system as well as a reimbursement approval in Japan for the same device will help it revive the dull Vascular business.
0
Cardiovascular Systems Stealth 360 Peripheral OAS Goes Global
http://www.zacks.com/stock/news/324017/cardiovascular-systems-stealth-360-peripheral-oas-goes-global?cid=CS-ZC-FT-324017
Sep 20, 2018 - Following the recent extension of its partnership with OrbusNeich, Cardiovascular Systems' (CSII) Stealth 360 Peripheral OAS is put to first commercial use in Hong Kong.
0
Here's Why You Should Hold on to Align Technology (ALGN) Now
http://www.zacks.com/stock/news/323771/heres-why-you-should-hold-on-to-align-technology-algn-now?cid=CS-ZC-FT-323771
Sep 19, 2018 - Continued strength in Align Technology's (ALGN) Invisalign volumes impresses. Overdependence on Invisalign Technology system is a concern.
0
Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now
http://www.zacks.com/stock/news/323817/heres-why-you-should-hold-angiodynamics-ango-stock-now?cid=CS-ZC-FT-323817
Sep 19, 2018 - AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.
0
Veeva's Vault CDMS to Unify Clinical Data in Single Platform
http://www.zacks.com/stock/news/323815/veevas-vault-cdms-to-unify-clinical-data-in-single-platform?cid=CS-ZC-FT-323815
Sep 19, 2018 - Veeva's (VEEV) cloud-based applications' market prospects bright.
0
Here's Why You Should Invest in Masimo (MASI) Right Now
http://www.zacks.com/stock/news/323694/heres-why-you-should-invest-in-masimo-masi-right-now?cid=CS-ZC-FT-323694
Sep 18, 2018 - A raised guidance for 2018 and positive developments make Masimo (MASI) a lucrative choice for investors.
0
Page 1>
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| EW | Edwards Lifesciences Corporation | NYSE | $146.29 | $30.63B |
| ALGN | Align Technology, Inc. | NASDAQ | $378.52 | $30.4B |
| ZBH | Zimmer Biomet Holdings, Inc. | NYSE | $129.55 | $26.36B |
| SNN | Smith & Nephew SNATS, Inc. | NYSE | $37.44 | $16.37B |
| STE | STERIS plc | NYSE | $113.1 | $9.56B |